Female Infertility Treatment Drugs Market, by Therapy (Gonadotropins, Clomiphene, Letrozole, Metformin, Leuprolide Acetate, Bromocriptine, Estrogens, Ganirelix Acetate, Cetrotide Acetate, and Progesterone), by Route of Administration (Oral and Injectable)

Female Infertility Treatment Drugs Market, by Therapy (Gonadotropins, Clomiphene, Letrozole, Metformin, Leuprolide Acetate, Bromocriptine, Estrogens, Ganirelix Acetate, Cetrotide Acetate, and Progesterone), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Female infertility refers to a condition where a woman is unable to conceive after at least one year of having unprotected sex. Various factors such as age, hormone imbalance, physical health, and lifestyle can lead to female infertility. Ovulation testing, Hysterosalpingography, and ovarian reserve testing are few of the tests used to diagnose female infertility. Ovarian reserve testing is highly recommended for women over the age of 35 years. Ovulation testing involves two tests viz. Luteinizing Hormone (LH) test and Follicle-Stimulating Hormone (FSH) test to check for ovulation which can aid in finding out the cause of infertility.
Female infertility can be treated using surgical methods such as Laparoscopic or hysteroscopic surgery and Tubal surgeries. These surgeries are performed to remove or correct abnormalities to help improve chances of getting pregnant. The surgeries can be performed to correct abnormal uterine shape, removing endometrial polyps and some types of fibroids that misshape the uterine cavity, or removing pelvic or uterine adhesions. In some cases, the fallopian tubes may be blocked or filled with fluid (hydrosalpinx). Tubal surgeries are performed to remove adhesions, dilate a tube or create a new tubal opening. Tubal surgeries are performed to remove adhesions, dilate a tube or create a new tubal opening. The global fertility rate is dropping at an alarming rate which is expected to drive the market growth of female infertility treatment drugs market over the forecast period. According to the Institute for Health Metrics and Evaluation, University of Washington, in 1950 the global fertility rate was 4.7 which halved to 2.4 in 2017 and is expected to drop as low as 1.7 in the near future.

Market Dynamics

Market players are focusing on various growth strategies such as agreements, partnerships, and collaborations to accelerate the development of drugs for infertility treatment, which is expected to boost growth of the global female infertility treatment drugs market over the forecast period. For instance, in January 2021, Bayer AG announced the expansion of their partnership with Evotec SE, a biotechnology company focusing on women health, with a new five-year, multi-target collaboration to develop multiple clinical candidates for the treatment of polycystic ovary syndrome (PCOS), which is one of the causes of infertility in females.
Moreover, in January 2019, Ferring Pharmaceuticals, a biopharmaceutical company entered into an exclusive agreement with Sun Pharmaceutical Industries Ltd., an India-based multinational pharmaceutical company to acquire the U.S. commercialization rights for a generic version of Ganirelix Acetate injection which is used for treatment of female infertility.

Key features of the study:
This report provides an in-depth analysis of global female infertility treatment drugs market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global female infertility treatment drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Ferring Pharmaceuticals, Merck & Co., Inc., Bayer AG, Abbott Laboratories, Par Pharmaceutical, Inc., Sumitovant, Livzon, Zydus Cadila, Oxolife, and Mankind Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global female infertility treatment drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the female infertility treatment drugs market
Detailed Segmentation:
Global Female Infertility Treatment Drugs Market, By Therapy:
Gonadotropins
Clomiphene
Letrozole
Metformin
Leuprolide Acetate
Bromocriptine
Estrogens
Ganirelix Acetate
Cetrotide Acetate
Progesterone
Global Female Infertility Treatment Drugs Market, By Route of Administration:
Oral
Injectable
Global Female Infertility Treatment Drugs Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Female Infertility Treatment Drugs Market, By Region:
North America
By Therapy:
Gonadotropins
Clomiphene
Letrozole
Metformin
Leuprolide Acetate
Bromocriptine
Estrogens
Ganirelix Acetate
Cetrotide Acetate
Progesterone
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Therapy:
Gonadotropins
Clomiphene
Letrozole
Metformin
Leuprolide Acetate
Bromocriptine
Estrogens
Ganirelix Acetate
Cetrotide Acetate
Progesterone
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Therapy:
Gonadotropins
Clomiphene
Letrozole
Metformin
Leuprolide Acetate
Bromocriptine
Estrogens
Ganirelix Acetate
Cetrotide Acetate
Progesterone
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Therapy:
Gonadotropins
Clomiphene
Letrozole
Metformin
Leuprolide Acetate
Bromocriptine
Estrogens
Ganirelix Acetate
Cetrotide Acetate
Progesterone
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
By Therapy:
Gonadotropins
Clomiphene
Letrozole
Metformin
Leuprolide Acetate
Bromocriptine
Estrogens
Ganirelix Acetate
Cetrotide Acetate
Progesterone
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Therapy:
Gonadotropins
Clomiphene
Letrozole
Metformin
Leuprolide Acetate
Bromocriptine
Estrogens
Ganirelix Acetate
Cetrotide Acetate
Progesterone
By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region/Country:
South Africa
Central Africa
North Africa

Company Profiles
Ferring Pharmaceuticals*
Company Highlights
Therapys Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co., Inc.
Bayer AG
Abbott Laboratories
Par Pharmaceutical, Inc.
Sumitovant
Livzon
Zydus Cadila
Oxolife
Mankind Pharma

“*” marked represents similar segmentation in other categories in the respective section.